Ticker
ALLOCompany Name
ALLOGENE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -173.6M | -75.23% | $ 230.76M |
3/31/2025 | $ -198.12M | -80.15% | $ 247.17M |
12/31/2024 | $ -200.99M | -48.95% | $ 410.63M |
9/30/2024 | $ -217.93M | -32.58% | $ 668.85M |
6/30/2024 | $ -228.93M | -44.32% | $ 516.51M |
3/31/2024 | $ -227.48M | -45.91% | $ 495.47M |
12/31/2023 | $ -239.25M | -31.48% | $ 760.07M |
9/30/2023 | $ -249.15M | -49.85% | $ 499.78M |
6/30/2023 | $ -241.49M | -30.72% | $ 786.17M |
3/31/2023 | $ -223.25M | -26.76% | $ 834.21M |
FCF / Market Cap
(=) FCF Yield
FCF Yield for ALLOGENE THERAPEUTICS INC is calculated as follows: FCF [ $ -218.05M ] / Market Cap [ $ 4.36B ]
(=) FCF Yield [ -5% ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.59% |
median | 3.22% |
std | 11.38% |